首页 > 最新文献

Zhonghua wei zhong bing ji jiu yi xue最新文献

英文 中文
[Development and validation of a predictive model for acute respiratory distress syndrome in geriatric patients following gastrointestinal perforation surgery]. [胃肠穿孔手术后老年患者急性呼吸窘迫综合征预测模型的建立和验证]。
Q3 Medicine Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn121430-20250409-00345
Ze Zhang, You Fu, Jing Yuan, Quansheng Du
<p><strong>Objective: </strong>To identify the risk factors for acute respiratory distress syndrome (ARDS) in geriatric patients following gastrointestinal perforation surgery, and constructed a model to validate its predictive value.</p><p><strong>Methods: </strong>A retrospective analysis was conducted. The clinical data of geriatric patients (aged ≥ 60 years) after gastrointestinal perforation surgery admitted to the intensive care unit (ICU) of Hebei General Hospital from October 2017 to October 2024 were enrolled. Two groups were divided according to whether ARDS occurred postoperatively, and the differences in each index between the groups were compared. Lasso regression and multifactorial Logistic regression analyses were used to identify independent risk factors for the development of ARDS, and a prediction model was constructed based on these, which was presented using a nomogram. The receiver operator characteristic curve (ROC curve), calibration curve, and decision curve analysis (DCA) were plotted to evaluate the discrimination, accuracy, and clinical practicability of the model.</p><p><strong>Results: </strong>A total of 155 geriatric patients following gastrointestinal perforation surgery were ultimately included in the analysis, among whom 43 developed ARDS, with an incidence rate of 27.7%. There were significantly differences in age, body mass index (BMI), acute kidney injury comorbidity, heart rate, onset time, the duration of surgery, the site of perforation, seroperitoneum, amount of bleeding, shock comorbidity, central venous pressure (CVP), C-reactive protein, and albumin between ARDS and non-ARDS groups. Lasso regression identified nine significant predictors: age, BMI, acute kidney injury comorbidity, onset time, seroperitoneum, shock comorbidity, CVP, hemoglobin, and albumin. Multivariate Logistic regression analysis identified BMI [odds ratio (OR) = 1.310, P < 0.001], hemoglobin (OR = 1.019, P = 0.045), seroperitoneum (OR = 1.001, P = 0.017), and albumin (OR = 0.871, P < 0.001) as independent risk factors for the occurrence of ARDS. A prediction model was constructed based on the above four independent risk factors, and the ROC curve showed that the area under the curve (AUC) of the model for predicting the occurrence of ARDS was 0.885 [95% confidence interval (95%CI) was 0.824-0.946], and internal validation was performed using bootstrap resampling (Bootstrap 500 times), which showed that the AUC value of the model was 0.886 (95%CI was 0.883-0.889). Calibration curves revealed excellent concordance between observed outcomes and model predictions. DCA indicated a high net benefit value for the model, which has good clinical utility.</p><p><strong>Conclusions: </strong>BMI, hemoglobin, seroperitoneum, and albumin were identified as independent risk factors for ARDS in geriatric patients following gastrointestinal perforation surgery. The prediction model constructed using these four indicators facilitates early identificat
目的:探讨老年患者胃肠道穿孔术后急性呼吸窘迫综合征(ARDS)发生的危险因素,并构建模型验证其预测价值。方法:回顾性分析。选取2017年10月至2024年10月河北省总医院重症监护病房(ICU)住院的胃肠穿孔术后老年患者(年龄≥60岁)的临床资料。根据术后是否发生ARDS分为两组,比较两组间各项指标的差异。采用Lasso回归和多因素Logistic回归分析确定ARDS发展的独立危险因素,并在此基础上构建预测模型。绘制受试者特征曲线(ROC曲线)、校正曲线和决策曲线分析(DCA),评价模型的辨别性、准确性和临床实用性。结果:155例胃肠穿孔手术后的老年患者最终纳入分析,其中43例发生ARDS,发生率为27.7%。ARDS组与非ARDS组在年龄、体重指数(BMI)、急性肾损伤合并症、心率、发病时间、手术时间、穿孔部位、浆膜、出血量、休克合并症、中心静脉压(CVP)、c反应蛋白、白蛋白等方面存在显著差异。Lasso回归确定了9个显著的预测因子:年龄、BMI、急性肾损伤合并症、发病时间、血清腹膜、休克合并症、CVP、血红蛋白和白蛋白。多因素Logistic回归分析发现,BMI[比值比(OR) = 1.310, P < 0.001]、血红蛋白(OR = 1.019, P = 0.045)、血清腹膜(OR = 1.001, P = 0.017)、白蛋白(OR = 0.871, P < 0.001)是ARDS发生的独立危险因素。基于以上4个独立危险因素构建预测模型,ROC曲线显示模型预测ARDS发生的曲线下面积(AUC)为0.885[95%可信区间(95% ci)为0.824-0.946],采用bootstrap重采样(bootstrap 500次)进行内部验证,模型的AUC值为0.886 (95% ci为0.883-0.889)。校准曲线显示观测结果与模型预测之间具有良好的一致性。DCA显示该模型具有较高的净效益值,具有良好的临床应用价值。结论:BMI、血红蛋白、血清腹膜和白蛋白被确定为胃肠道穿孔手术后老年患者ARDS的独立危险因素。利用这四个指标构建的预测模型有助于临床医生早期识别高危人群。
{"title":"[Development and validation of a predictive model for acute respiratory distress syndrome in geriatric patients following gastrointestinal perforation surgery].","authors":"Ze Zhang, You Fu, Jing Yuan, Quansheng Du","doi":"10.3760/cma.j.cn121430-20250409-00345","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250409-00345","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To identify the risk factors for acute respiratory distress syndrome (ARDS) in geriatric patients following gastrointestinal perforation surgery, and constructed a model to validate its predictive value.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective analysis was conducted. The clinical data of geriatric patients (aged ≥ 60 years) after gastrointestinal perforation surgery admitted to the intensive care unit (ICU) of Hebei General Hospital from October 2017 to October 2024 were enrolled. Two groups were divided according to whether ARDS occurred postoperatively, and the differences in each index between the groups were compared. Lasso regression and multifactorial Logistic regression analyses were used to identify independent risk factors for the development of ARDS, and a prediction model was constructed based on these, which was presented using a nomogram. The receiver operator characteristic curve (ROC curve), calibration curve, and decision curve analysis (DCA) were plotted to evaluate the discrimination, accuracy, and clinical practicability of the model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 155 geriatric patients following gastrointestinal perforation surgery were ultimately included in the analysis, among whom 43 developed ARDS, with an incidence rate of 27.7%. There were significantly differences in age, body mass index (BMI), acute kidney injury comorbidity, heart rate, onset time, the duration of surgery, the site of perforation, seroperitoneum, amount of bleeding, shock comorbidity, central venous pressure (CVP), C-reactive protein, and albumin between ARDS and non-ARDS groups. Lasso regression identified nine significant predictors: age, BMI, acute kidney injury comorbidity, onset time, seroperitoneum, shock comorbidity, CVP, hemoglobin, and albumin. Multivariate Logistic regression analysis identified BMI [odds ratio (OR) = 1.310, P &lt; 0.001], hemoglobin (OR = 1.019, P = 0.045), seroperitoneum (OR = 1.001, P = 0.017), and albumin (OR = 0.871, P &lt; 0.001) as independent risk factors for the occurrence of ARDS. A prediction model was constructed based on the above four independent risk factors, and the ROC curve showed that the area under the curve (AUC) of the model for predicting the occurrence of ARDS was 0.885 [95% confidence interval (95%CI) was 0.824-0.946], and internal validation was performed using bootstrap resampling (Bootstrap 500 times), which showed that the AUC value of the model was 0.886 (95%CI was 0.883-0.889). Calibration curves revealed excellent concordance between observed outcomes and model predictions. DCA indicated a high net benefit value for the model, which has good clinical utility.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;BMI, hemoglobin, seroperitoneum, and albumin were identified as independent risk factors for ARDS in geriatric patients following gastrointestinal perforation surgery. The prediction model constructed using these four indicators facilitates early identificat","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 8","pages":"749-754"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Construction of a risk prediction model for the timing of extracorporeal membrane oxygenation initiation]. [体外膜氧合起始时间风险预测模型的构建]。
Q3 Medicine Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn121430-20241129-00971
Dehua Zeng, Xifeng Liu, Zhibiao He, Aiqun Zhu
<p><strong>Objective: </strong>To identify the risk factors related to the timing of patients receiving extracorporeal membrane oxygenation (ECMO) initiation and construct a risk prediction model for ECMO initiation timing.</p><p><strong>Methods: </strong>Patients who received ECMO admitted to the Second Xiangya Hospital of Central South University from January 2020 to January 2024 were retrospectively collected. The case data mainly included physiological and biochemical indicators 1 hour before ECMO initiation. According to the outcome of the patients, they were divided into survival group and death group. Univariate and multivariate Logistic regression analysis were used to analyze the predictors of mortality risk in patients with ECMO, and a nomogram prediction model was constructed. The discrimination, calibration accuracy, and goodness of the model were evaluated by the receiver operator characteristic curve (ROC curve), calibration curve, and the Hosmer-Lemeshow test, respectively. Decision curve analysis (DCA) evaluated the clinical net benefit rate of the model.</p><p><strong>Results: </strong>A total of 81 ECMO patients were included, including 59 males and 22 females; age range from 16 to 61 years old, with a median age of 56.0 (39.5, 61.5) years old; 20 patients received veno-arterial (V-A) ECMO, and 61 patients received veno-venous (V-V) ECMO; 23 patients ultimately survived and 58 patients died. Univariate analysis showed that age, blood urea nitrogen, serum creatinine, D-dimer, arterial blood carbon dioxide partial pressure, and prothrombin time of the death group were all higher than those of the survival group, while albumin was slightly lower than that of the survival group. There was a statistically significant difference in the direct cause of ECMO initiation between the two groups. Multivariate Logistic regression analysis showed that age [odds ratio (OR) = 1.069, 95% confidence interval (95%CI) was 1.015-1.125, P = 0.012], direct cause of ECMO initiation [with heart failure as the reference, return of spontaneous circulation (ROSC) after cardiopulmonary support (OR = 30.672, 95%CI was 1.265-743.638, P = 0.035), novel coronavirus infection (OR = 8.666, 95%CI was 0.818-91.761, P = 0.073), other severe pneumonia (OR = 4.997, 95%CI was 0.558-44.765, P = 0.150)], pre-ECMO serum creatinine (OR = 1.008, 95%CI was 1.000-1.016, P = 0.044), prothrombin time (OR = 1.078, 95%CI was 0.948-1.226, P = 0.252), and D-dimer (OR = 1.135, 95%CI was 1.047-1.231, P = 0.002) were entered into the final regression equation. A nomogram prediction model was developed based on these five factors. The area under the ROC curve (AUC) of the model was 0.889 (95%CI was 0.819-0.959), higher than the AUC of the sequential organ failure assessment (SOFA; AUC = 0.604, 95%CI was 0.467-0.742). The calibration curve showed good consistency between the model predictions and the observed results. The Hosmer-Lemeshow goodness-of-fit test showed that χ <sup>2</sup> =
目的:探讨影响患者接受体外膜氧合(ECMO)启动时间的危险因素,构建ECMO启动时间的风险预测模型。方法:回顾性收集2020年1月至2024年1月在中南大学湘雅第二医院接受ECMO的患者。病例资料主要包括ECMO启动前1小时的生理生化指标。根据患者预后情况分为生存组和死亡组。采用单因素和多因素Logistic回归分析对ECMO患者死亡风险的预测因素进行分析,并构建nomogram预测模型。采用受试者特征曲线(ROC曲线)、校正曲线和Hosmer-Lemeshow检验分别评价模型的判别性、校正精度和优度。决策曲线分析(Decision curve analysis, DCA)评价模型的临床净效益率。结果:共纳入ECMO患者81例,其中男性59例,女性22例;年龄16 ~ 61岁,中位年龄56.0(39.5,61.5)岁;静脉-动脉(V-A) ECMO 20例,静脉-静脉(V-V) ECMO 61例;23名患者最终存活,58名患者死亡。单因素分析显示,死亡组的年龄、血尿素氮、血清肌酐、d -二聚体、动脉血二氧化碳分压、凝血酶原时间均高于生存组,白蛋白略低于生存组。两组ECMO启动的直接原因有统计学差异。多因素Logistic回归分析显示,年龄[优势比(OR) = 1.069, 95%可信区间(95% ci)为1.015 ~ 1.125,P = 0.012]、启动ECMO的直接原因[以心力衰竭为参照,心肺支持后自主循环恢复(ROSC) (OR = 30.672, 95% ci为1.265 ~ 743.638,P = 0.035)、新型冠状病毒感染(OR = 8.666, 95% ci为0.818 ~ 91.761,P = 0.073)、其他重症肺炎(OR = 4.997, 95% ci为0.558 ~ 44.765,P = 0.150)]、将ecmo前血清肌酐(OR = 1.008, 95%CI为1.000 ~ 1.016,P = 0.044)、凝血酶原时间(OR = 1.078, 95%CI为0.948 ~ 1.226,P = 0.252)、d -二聚体(OR = 1.135, 95%CI为1.047 ~ 1.231,P = 0.002)纳入最终回归方程。基于这五个因素,建立了一种nomogram预测模型。模型的ROC曲线下面积(AUC)为0.889 (95%CI为0.819 ~ 0.959),高于序贯器官衰竭评价的AUC (SOFA; AUC = 0.604, 95%CI为0.467 ~ 0.742)。校正曲线显示,模型预测值与观测结果具有较好的一致性。Hosmer-Lemeshow拟合优度检验显示χ 2 = 4.668, P = 0.792。DCA分析显示,当风险阈值为0-0.8时,净效益率大于0,显著优于SOFA评分。结论:采用年龄、ECMO启动的直接原因、凝血酶时间、血清肌酐、d -二聚体等5个因素构建的ECMO启动时间风险预测模型具有良好的判别性和校准性。它可以作为启动前评估工具来识别和预测ECMO患者启动后的死亡风险。
{"title":"[Construction of a risk prediction model for the timing of extracorporeal membrane oxygenation initiation].","authors":"Dehua Zeng, Xifeng Liu, Zhibiao He, Aiqun Zhu","doi":"10.3760/cma.j.cn121430-20241129-00971","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20241129-00971","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To identify the risk factors related to the timing of patients receiving extracorporeal membrane oxygenation (ECMO) initiation and construct a risk prediction model for ECMO initiation timing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Patients who received ECMO admitted to the Second Xiangya Hospital of Central South University from January 2020 to January 2024 were retrospectively collected. The case data mainly included physiological and biochemical indicators 1 hour before ECMO initiation. According to the outcome of the patients, they were divided into survival group and death group. Univariate and multivariate Logistic regression analysis were used to analyze the predictors of mortality risk in patients with ECMO, and a nomogram prediction model was constructed. The discrimination, calibration accuracy, and goodness of the model were evaluated by the receiver operator characteristic curve (ROC curve), calibration curve, and the Hosmer-Lemeshow test, respectively. Decision curve analysis (DCA) evaluated the clinical net benefit rate of the model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 81 ECMO patients were included, including 59 males and 22 females; age range from 16 to 61 years old, with a median age of 56.0 (39.5, 61.5) years old; 20 patients received veno-arterial (V-A) ECMO, and 61 patients received veno-venous (V-V) ECMO; 23 patients ultimately survived and 58 patients died. Univariate analysis showed that age, blood urea nitrogen, serum creatinine, D-dimer, arterial blood carbon dioxide partial pressure, and prothrombin time of the death group were all higher than those of the survival group, while albumin was slightly lower than that of the survival group. There was a statistically significant difference in the direct cause of ECMO initiation between the two groups. Multivariate Logistic regression analysis showed that age [odds ratio (OR) = 1.069, 95% confidence interval (95%CI) was 1.015-1.125, P = 0.012], direct cause of ECMO initiation [with heart failure as the reference, return of spontaneous circulation (ROSC) after cardiopulmonary support (OR = 30.672, 95%CI was 1.265-743.638, P = 0.035), novel coronavirus infection (OR = 8.666, 95%CI was 0.818-91.761, P = 0.073), other severe pneumonia (OR = 4.997, 95%CI was 0.558-44.765, P = 0.150)], pre-ECMO serum creatinine (OR = 1.008, 95%CI was 1.000-1.016, P = 0.044), prothrombin time (OR = 1.078, 95%CI was 0.948-1.226, P = 0.252), and D-dimer (OR = 1.135, 95%CI was 1.047-1.231, P = 0.002) were entered into the final regression equation. A nomogram prediction model was developed based on these five factors. The area under the ROC curve (AUC) of the model was 0.889 (95%CI was 0.819-0.959), higher than the AUC of the sequential organ failure assessment (SOFA; AUC = 0.604, 95%CI was 0.467-0.742). The calibration curve showed good consistency between the model predictions and the observed results. The Hosmer-Lemeshow goodness-of-fit test showed that χ &lt;sup&gt;2&lt;/sup&gt; =","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 8","pages":"762-767"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A randomized controlled trial on light music therapy for preventing intensive care unit delirium in patients undergoing invasive mechanical ventilation]. [轻音乐治疗预防重症监护病房有创机械通气患者谵妄的随机对照试验]。
Q3 Medicine Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn121430-20250302-00200
Xiaqin Liu, Li'an Tang, Caihong Wang, Debin Huang
<p><strong>Objective: </strong>To explore the effect of light music therapy on delirium in intensive care unit (ICU) patients undergoing invasive mechanical ventilation, and provide evidence-based support for clinical prevention of delirium.</p><p><strong>Methods: </strong>A prospective randomized controlled trial was conducted. 140 patients with invasive mechanical ventilation admitted to the department of respiratory and critical care medicine of First Affiliated Hospital of Guangxi Medical University from January 2024 to January 2025 were enrolled. The patients were divided into intervention group and control group using a random number table method. The control group received routine treatment and nursing care, while the intervention group received light music therapy three times a day for 30 minutes each time for 7 consecutive days. The confusion assessment method-ICU (CAM-ICU) was used to evaluate delirium, and the incidence of delirium within 7 days was statistically analyzed. Richmond agitation-sedation score (RASS), critical care pain observation tool (CPOT) score, mechanical ventilation duration, the length of ICU stay, and ICU stay expenses were record.</p><p><strong>Results: </strong>129 cases were ultimately included, including 64 cases in the control group and 65 cases in the intervention group. There was no statistically significant difference in baseline data between the two groups, indicating comparability. The incidence of delirium in the intervention group was significantly lower than that in the control group (27.7% vs. 51.6%, χ <sup>2</sup> = 7.687, P = 0.006). There was no significantly difference in RASS score between the two groups before enrollment (P = 0.840). After intervention, the RASS score in the intervention group significantly decreased, from 2.00 points on the 1st day of enrollment to 0.00 points on the 7th day, while the control group only decreased from 2.00 points to 1.50 points. The decreasing trend of the intervention group was more pronounced, especially on the 3rd day (P = 0.047) and the 7th day (P =0.005), with significant differences between the groups. The time effect (F = 18.929, P < 0.001), group effect (F = 6.655, P = 0.011), and time group interaction effect (F = 7.372, P < 0.001) of the two groups of RASS score were significant, suggesting that light music therapy has better timeliness and sustainability in improving patients' sedation status. There was no significantly difference in CPOT score between the two groups before enrollment (P = 0.902). After intervention, the CPOT score in the intervention group rapidly decreased from 3.00 points before enrollment to 1.00 points on the 1st day, and continued until the 7th day, while the control group showed a slower decrease from 2.50 points to 2.00 points and only dropped to 1.00 points on the 7th day. There were significant differences on 1st day and 3rd day between two groups (both P < 0.05). The time effect (F = 28.125, P < 0.001), group effect (F =
目的:探讨轻音乐治疗对重症监护病房(ICU)有创机械通气患者谵妄的影响,为临床预防谵妄提供循证支持。方法:采用前瞻性随机对照试验。选取2024年1月至2025年1月广西医科大学第一附属医院呼吸与重症医学科收治的140例有创机械通气患者。采用随机数字表法将患者分为干预组和对照组。对照组接受常规治疗及护理,干预组接受轻音乐治疗,每天3次,每次30分钟,连续7天。采用神志不清评价法- icu (CAM-ICU)评价谵妄,统计分析7 d内谵妄的发生率。记录患者的Richmond激动镇静评分(RASS)、重症监护疼痛观察工具评分(CPOT)、机械通气时间、ICU住院时间、ICU住院费用。结果:最终纳入129例,其中对照组64例,干预组65例。两组基线数据无统计学差异,具有可比性。干预组谵妄发生率显著低于对照组(27.7% vs. 51.6%, χ 2 = 7.687, P = 0.006)。两组患者入组前RASS评分差异无统计学意义(P = 0.840)。干预后,干预组RASS评分从入组第1天的2.00分显著下降到第7天的0.00分,而对照组仅从2.00分下降到1.50分。干预组下降趋势更为明显,特别是在第3天(P = 0.047)和第7天(P =0.005),组间差异有统计学意义。两组RASS评分的时间效应(F = 18.929, P < 0.001)、组效应(F = 6.655, P = 0.011)、时间组交互效应(F = 7.372, P < 0.001)均显著,提示轻音乐治疗在改善患者镇静状态方面具有较好的时效性和可持续性。两组患者入组前CPOT评分差异无统计学意义(P = 0.902)。干预后,干预组的CPOT评分从入组前的3.00分迅速下降到第1天的1.00分,并持续到第7天,而对照组的CPOT评分从2.50分下降到2.00分,下降速度较慢,到第7天仅下降到1.00分。第1天、第3天两组比较差异均有统计学意义(P < 0.05)。时间效应(F = 28.125, P < 0.001),组效应(F = 11.580, P = 0.001),和时间组交互作用(F = 4.048, P = 0.020) CPOT两组的得分显著,表明光音乐疗法有更好的疼痛控制,但交互效应较低,表明干预CPOT分数的影响主要集中在早期阶段(1 - 3天),和长期影响可能会受到其他因素的影响。与对照组比较,干预组机械通气时间(10.57±2.94天∶11.95±3.74天,P = 0.021)和ICU住院时间(14.91±4.37天∶17.53±4.83天,P = 0.002)显著减少。干预组ICU住院费用略低于对照组[万元:22.431(12.473,28.489)比29.362(11.996,41.389)],但差异无统计学意义(P = 0.086)。结论:轻音乐治疗可有效降低有创机械通气患者谵妄的发生率,改善意识和疼痛感知,缩短机械通气时间和住院时间,具有重要的临床推广价值。
{"title":"[A randomized controlled trial on light music therapy for preventing intensive care unit delirium in patients undergoing invasive mechanical ventilation].","authors":"Xiaqin Liu, Li'an Tang, Caihong Wang, Debin Huang","doi":"10.3760/cma.j.cn121430-20250302-00200","DOIUrl":"10.3760/cma.j.cn121430-20250302-00200","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To explore the effect of light music therapy on delirium in intensive care unit (ICU) patients undergoing invasive mechanical ventilation, and provide evidence-based support for clinical prevention of delirium.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A prospective randomized controlled trial was conducted. 140 patients with invasive mechanical ventilation admitted to the department of respiratory and critical care medicine of First Affiliated Hospital of Guangxi Medical University from January 2024 to January 2025 were enrolled. The patients were divided into intervention group and control group using a random number table method. The control group received routine treatment and nursing care, while the intervention group received light music therapy three times a day for 30 minutes each time for 7 consecutive days. The confusion assessment method-ICU (CAM-ICU) was used to evaluate delirium, and the incidence of delirium within 7 days was statistically analyzed. Richmond agitation-sedation score (RASS), critical care pain observation tool (CPOT) score, mechanical ventilation duration, the length of ICU stay, and ICU stay expenses were record.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;129 cases were ultimately included, including 64 cases in the control group and 65 cases in the intervention group. There was no statistically significant difference in baseline data between the two groups, indicating comparability. The incidence of delirium in the intervention group was significantly lower than that in the control group (27.7% vs. 51.6%, χ &lt;sup&gt;2&lt;/sup&gt; = 7.687, P = 0.006). There was no significantly difference in RASS score between the two groups before enrollment (P = 0.840). After intervention, the RASS score in the intervention group significantly decreased, from 2.00 points on the 1st day of enrollment to 0.00 points on the 7th day, while the control group only decreased from 2.00 points to 1.50 points. The decreasing trend of the intervention group was more pronounced, especially on the 3rd day (P = 0.047) and the 7th day (P =0.005), with significant differences between the groups. The time effect (F = 18.929, P &lt; 0.001), group effect (F = 6.655, P = 0.011), and time group interaction effect (F = 7.372, P &lt; 0.001) of the two groups of RASS score were significant, suggesting that light music therapy has better timeliness and sustainability in improving patients' sedation status. There was no significantly difference in CPOT score between the two groups before enrollment (P = 0.902). After intervention, the CPOT score in the intervention group rapidly decreased from 3.00 points before enrollment to 1.00 points on the 1st day, and continued until the 7th day, while the control group showed a slower decrease from 2.50 points to 2.00 points and only dropped to 1.00 points on the 7th day. There were significant differences on 1st day and 3rd day between two groups (both P &lt; 0.05). The time effect (F = 28.125, P &lt; 0.001), group effect (F =","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 8","pages":"735-740"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Association between fluid balance trajectory and 28-day mortality and continuous renal replacement therapy in patients with severe acute pancreatitis]. [重症急性胰腺炎患者体液平衡轨迹与28天死亡率和持续肾脏替代治疗的关系]。
Q3 Medicine Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn121430-20250427-00399
Songxun Tang, Jiong Xiong, Fangqi Wu, Fuyu Deng, Tingting Li, Xu Liu, Yan Tang, Feng Shen

Objective: To investigate the association between fluid balance trajectories within the first 3 days of intensive care unit (ICU) admission and 28-day mortality as well as the incidence of continuous renal replacement therapy (CRRT) in patients with severe acute pancreatitis (SAP).

Methods: Clinical data of SAP patients were extracted from the Medical Information Mart of Intensive Care-IV (MIMIC-IV). Group-based trajectory modeling (GBTM) was used to analyze the daily fluid balance of patients within 3 days of ICU admission, and grouping them accordingly. Univariate and multivariate Logistic regression analyses were performed to assess the association between fluid balance trajectory and 28-day mortality and ICU CRRT in SAP patients.

Results: A total of 251 SAP patients were included, with 33 deaths within 28 days, and a 28-day mortality of 13.15%; 49 patients (19.52%) continued to receive bedside CRRT after 3 days of ICU admission. The fluid balance on the 3rd day, cumulative fluid balance within 3 days of ICU admission, and incidence of CRRT in the death group were significantly higher than those in the survival group. According to GBTM groups, there were 127 cases in the moderate fluid resuscitation with rapid reduction (MF group), 44 cases in the large fluid resuscitation with rapid reduction (LF group), 20 cases in the moderate fluid resuscitation with slow reduction (MS group), and 60 cases in the small fluid resuscitation with slow reduction (SS group). The cumulative fluid balance within 3 days of ICU admission of the MF group, LF group, MS group, and SS group were 8.60% (5.15%, 11.70%), 16.70% (13.00%, 21.02%), 23.40% (19.38%, 25.45%), and 0.65% (-2.35%, 2.20%), respectively, and the incidence of CRRT during ICU hospitalization were 11.02%, 29.55%, 85.00%, and 8.33%, respectively, with statistically significant differences among the groups (both P < 0.05); the 28-day mortality were 11.02%, 18.18%, 20.00%, and 11.67%, respectively, with no statistically significant difference among the groups (P > 0.05). Kaplan-Meier survival curve analysis showed there was no statistically significant difference in 28-day cumulative survival rate among groups with different fluid balance trajectories (Log-rank test: χ 2 = 2.31, P = 0.509). Multivariate Logistic regression analysis showed that cumulative fluid balance within 3 days of ICU admission was an independent risk factor for 28-day mortality [odds ratio (OR) = 1.071, 95% confidence interval (95%CI) was 1.005-1.144, P = 0.040] and CRRT requirement (OR = 1.233, 95%CI was 1.125-1.372, P < 0.001); early aggressive fluid resuscitation on day 1 reduced CRRT risk (OR = 0.866, 95%CI was 0.756-0.978, P = 0.030).

Conclusions: Dynamic fluid management is essential in SAP patients. While early aggressive fluid resuscitation may reduce CRRT demand, excessive cumulative fluid balance is associated with increased

目的:探讨重症监护病房(ICU)入院前3天液体平衡轨迹与重症重症胰腺炎(SAP)患者28天死亡率及持续肾替代治疗(CRRT)发生率的关系。方法:从重症监护医学信息市场- iv (MIMIC-IV)中提取SAP患者的临床资料。采用分组轨迹模型(Group-based trajectory modeling, GBTM)分析患者入院3 d内的每日体液平衡情况,并进行分组。采用单因素和多因素Logistic回归分析评估SAP患者体液平衡轨迹与28天死亡率和ICU CRRT之间的关系。结果:共纳入251例SAP患者,其中28天内死亡33例,28天死亡率为13.15%;49例(19.52%)患者在ICU入院3天后继续接受床边CRRT治疗。死亡组患者入院第3天体液平衡、入院第3天累积体液平衡、CRRT发生率均显著高于生存组。按GBTM组分,中度液体复苏快速复位(MF组)127例,重度液体复苏快速复位(LF组)44例,中度液体复苏缓慢复位(MS组)20例,轻度液体复苏缓慢复位(SS组)60例。MF组、LF组、MS组、SS组患者入院后3 d内累积体液平衡分别为8.60%(5.15%、11.70%)、16.70%(13.00%、21.02%)、23.40%(19.38%、25.45%)、0.65%(-2.35%、2.20%),住院期间CRRT发生率分别为11.02%、29.55%、85.00%、8.33%,组间差异均有统计学意义(P均< 0.05);28天死亡率分别为11.02%、18.18%、20.00%、11.67%,组间比较差异无统计学意义(P < 0.05)。Kaplan-Meier生存曲线分析显示,不同体液平衡轨迹组28天累积生存率差异无统计学意义(Log-rank检验:χ 2 = 2.31, P = 0.509)。多因素Logistic回归分析显示,ICU入院3 d内累积体液平衡是28天死亡率的独立危险因素[优势比(OR) = 1.071, 95%可信区间(95% ci)为1.005 ~ 1.144,P = 0.040]和CRRT要求(OR = 1.233, 95% ci为1.125 ~ 1.372,P < 0.001);第1天早期积极液体复苏降低CRRT风险(OR = 0.866, 95%CI为0.756 ~ 0.978,P = 0.030)。结论:动态体液管理对SAP患者至关重要。虽然早期积极的液体复苏可以减少CRRT的需求,但过度的累积液体平衡与28天死亡率和CRRT发生率增加有关。
{"title":"[Association between fluid balance trajectory and 28-day mortality and continuous renal replacement therapy in patients with severe acute pancreatitis].","authors":"Songxun Tang, Jiong Xiong, Fangqi Wu, Fuyu Deng, Tingting Li, Xu Liu, Yan Tang, Feng Shen","doi":"10.3760/cma.j.cn121430-20250427-00399","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250427-00399","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the association between fluid balance trajectories within the first 3 days of intensive care unit (ICU) admission and 28-day mortality as well as the incidence of continuous renal replacement therapy (CRRT) in patients with severe acute pancreatitis (SAP).</p><p><strong>Methods: </strong>Clinical data of SAP patients were extracted from the Medical Information Mart of Intensive Care-IV (MIMIC-IV). Group-based trajectory modeling (GBTM) was used to analyze the daily fluid balance of patients within 3 days of ICU admission, and grouping them accordingly. Univariate and multivariate Logistic regression analyses were performed to assess the association between fluid balance trajectory and 28-day mortality and ICU CRRT in SAP patients.</p><p><strong>Results: </strong>A total of 251 SAP patients were included, with 33 deaths within 28 days, and a 28-day mortality of 13.15%; 49 patients (19.52%) continued to receive bedside CRRT after 3 days of ICU admission. The fluid balance on the 3rd day, cumulative fluid balance within 3 days of ICU admission, and incidence of CRRT in the death group were significantly higher than those in the survival group. According to GBTM groups, there were 127 cases in the moderate fluid resuscitation with rapid reduction (MF group), 44 cases in the large fluid resuscitation with rapid reduction (LF group), 20 cases in the moderate fluid resuscitation with slow reduction (MS group), and 60 cases in the small fluid resuscitation with slow reduction (SS group). The cumulative fluid balance within 3 days of ICU admission of the MF group, LF group, MS group, and SS group were 8.60% (5.15%, 11.70%), 16.70% (13.00%, 21.02%), 23.40% (19.38%, 25.45%), and 0.65% (-2.35%, 2.20%), respectively, and the incidence of CRRT during ICU hospitalization were 11.02%, 29.55%, 85.00%, and 8.33%, respectively, with statistically significant differences among the groups (both P < 0.05); the 28-day mortality were 11.02%, 18.18%, 20.00%, and 11.67%, respectively, with no statistically significant difference among the groups (P > 0.05). Kaplan-Meier survival curve analysis showed there was no statistically significant difference in 28-day cumulative survival rate among groups with different fluid balance trajectories (Log-rank test: χ <sup>2</sup> = 2.31, P = 0.509). Multivariate Logistic regression analysis showed that cumulative fluid balance within 3 days of ICU admission was an independent risk factor for 28-day mortality [odds ratio (OR) = 1.071, 95% confidence interval (95%CI) was 1.005-1.144, P = 0.040] and CRRT requirement (OR = 1.233, 95%CI was 1.125-1.372, P < 0.001); early aggressive fluid resuscitation on day 1 reduced CRRT risk (OR = 0.866, 95%CI was 0.756-0.978, P = 0.030).</p><p><strong>Conclusions: </strong>Dynamic fluid management is essential in SAP patients. While early aggressive fluid resuscitation may reduce CRRT demand, excessive cumulative fluid balance is associated with increased ","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 8","pages":"741-748"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Design and application of a pressure control device for the continuous renal replacement therapy integrated in-series with extracorporeal membrane oxygenation]. [体外膜氧合联合连续肾替代治疗压力控制装置的设计与应用]。
Q3 Medicine Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn121430-20250427-00401
Lianqing Pu, Xuezhu Li, Lu Ma, Guanjie Chen, Xiaoqing Li, Hui Chen

Patients requiring extracorporeal membrane oxygenation (ECMO) often need concurrent continuous renal replacement therapy (CRRT). At present, there are various connection methods between ECMO and CRRT circuits, among which in-series integration is the most common. However, ECMO blood flow and catheter type, pressure changes at the pre-pump, post-pump pre-oxygenator, and post-oxygenator segments frequently result in circuit pressures that exceed the alarm threshold of the device. Excessive negative or positive pressures may compromise blood withdrawal and return within the CRRT circuit, leading to frequent system alarms, interruptions in therapy, filter occlusion, and an increased risk of thrombus formation. To address this issue, the critical care nursing team of Zhongda Hospital Affiliated to Southeast University, developed a novel pressure-regulating clamp for CRRT vascular access in ECMO patient, which has been granted a National Utility Model Patent of China (patent number: ZL 2021 2 1496610.7). The device comprises opposing left and right clamp arms joined at the top by a flexible plastic bridge, with dual internal compression surfaces designed to fit CRRT tubing of various calibers. A locking mechanism and serrated strip at the base enable precise adjustment of the compression distance, thereby modulating the tubing's cross-sectional area. This configuration allows real-time regulation of blood flow and stabilization of pressures at blood withdrawal and return sites within the CRRT circuit. By reducing pressure-related alarms and extending filter life, the device may enhance the safety and efficiency of CRRT delivery during ECMO. It is user-friendly, cost-effective, and well-suited for broad clinical implementation, with the potential to alleviate the overall treatment burden on patients and their families.

需要体外膜氧合(ECMO)的患者通常需要同步持续肾替代治疗(CRRT)。目前,ECMO与CRRT电路之间的连接方式多种多样,其中串联集成最为常见。然而,ECMO血流和导管类型、泵前、泵后预充氧器和后充氧器段的压力变化经常导致回路压力超过设备的报警阈值。过高的负压或正压可能损害CRRT回路内的血液回流,导致系统频繁报警、治疗中断、滤过器阻塞和血栓形成的风险增加。针对这一问题,东南大学附属中大医院危重护理团队开发了一种用于ECMO患者CRRT血管通路的新型调压钳,并获得了中国国家实用新型专利(专利号:ZL 2021 2 1496610.7)。该装置包括相对的左右夹臂,顶部由柔性塑料桥连接,具有双重内部压缩表面,设计用于适应各种口径的CRRT管。底部的锁定机构和锯齿形条可以精确调整压缩距离,从而调节油管的横截面积。这种配置可以实时调节血流,稳定CRRT回路内血液提取和回流部位的压力。通过减少与压力相关的警报和延长过滤器寿命,该装置可以提高ECMO期间CRRT输送的安全性和效率。它用户友好,成本效益高,非常适合广泛的临床实施,有可能减轻患者及其家庭的整体治疗负担。
{"title":"[Design and application of a pressure control device for the continuous renal replacement therapy integrated in-series with extracorporeal membrane oxygenation].","authors":"Lianqing Pu, Xuezhu Li, Lu Ma, Guanjie Chen, Xiaoqing Li, Hui Chen","doi":"10.3760/cma.j.cn121430-20250427-00401","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250427-00401","url":null,"abstract":"<p><p>Patients requiring extracorporeal membrane oxygenation (ECMO) often need concurrent continuous renal replacement therapy (CRRT). At present, there are various connection methods between ECMO and CRRT circuits, among which in-series integration is the most common. However, ECMO blood flow and catheter type, pressure changes at the pre-pump, post-pump pre-oxygenator, and post-oxygenator segments frequently result in circuit pressures that exceed the alarm threshold of the device. Excessive negative or positive pressures may compromise blood withdrawal and return within the CRRT circuit, leading to frequent system alarms, interruptions in therapy, filter occlusion, and an increased risk of thrombus formation. To address this issue, the critical care nursing team of Zhongda Hospital Affiliated to Southeast University, developed a novel pressure-regulating clamp for CRRT vascular access in ECMO patient, which has been granted a National Utility Model Patent of China (patent number: ZL 2021 2 1496610.7). The device comprises opposing left and right clamp arms joined at the top by a flexible plastic bridge, with dual internal compression surfaces designed to fit CRRT tubing of various calibers. A locking mechanism and serrated strip at the base enable precise adjustment of the compression distance, thereby modulating the tubing's cross-sectional area. This configuration allows real-time regulation of blood flow and stabilization of pressures at blood withdrawal and return sites within the CRRT circuit. By reducing pressure-related alarms and extending filter life, the device may enhance the safety and efficiency of CRRT delivery during ECMO. It is user-friendly, cost-effective, and well-suited for broad clinical implementation, with the potential to alleviate the overall treatment burden on patients and their families.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 8","pages":"768-770"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role of CISD2 in sepsis-associated myocardial injury and its predictive value for 28-day prognosis]. [CISD2在脓毒症相关心肌损伤中的作用及其对28天预后的预测价值]。
Q3 Medicine Pub Date : 2025-08-01 DOI: 10.3760/cma.j.cn121430-20250305-00216
Bingchang Hei, Xiaobing Li, Xianguo Meng, Zhanjiang Guan, Shi Liu
<p><strong>Objective: </strong>To explore the role of CDGSH iron-sulfur domain 2 (CISD2) in patients with sepsis-related myocardial injury (SMI) and its predictive value for 28-day prognosis and myocardial damage through clinical studies and cell experiments.</p><p><strong>Methods: </strong>A retrospective study was conducted. Adult patients diagnosed with sepsis admitted to the critical care medicine of Third Affiliated Hospital of Qiqihar Medical University from January 2023 to January 2024 were enrolled. The clinical data, laboratory indicators, expression level of CISD2 mRNA in peripheral blood mononuclear cells (PBMC) 24 hours after admission, and 28 days prognosis were collected. Patients were divided into SMI group [left ventricular ejection fraction (LVEF) < 0.50 or LVEF decreased by ≥ 10% from baseline] and sepsis non-myocardial injury group based on LVEF. The expression levels of CISD2 mRNA were compared between the two groups, and the correlation between CISD2 and myocardial injury was analyzed. Patients were divided into the low-expression group (CISD2 mRNA < 0.5 copy/μL) and the high-expression group (CISD2 mRNA ≥ 0.5 copy/μL) based on the expression of CISD2 mRNA, and into the survival group and the death group based on the prognosis at 28 days. The clinical characteristics were analyzed between the groups. Multivariate Logistic regression was used to analyze the independent predictors of 28-day mortality in patients with sepsis. The predictive value of CISD2 for myocardial damage and 28-day prognosis in patients with sepsis were evaluated by using the receiver operator characteristic curve (ROC curve). In addition, in vitro experiments using human AC16 cardiomyocytes was conducted. The cells were divided into control group, lipopolysaccharide (LPS) group, the LPS+transfection group with overexpression of CISD2 plasmid (LPS+p-CISD2 group), and the LPS + transfection group with negative control plasmid (LPS+p-NC group). The mRNA expression of CISD2 in cells were detected by real-time quantitative polymerase chain reaction (RT-qPCR), the protein expression of CISD2 in cells were detected by Western blotting, and the cell viability was determined by cell counting kit-8 (CCK-8).</p><p><strong>Results: </strong>A total of 85 sepsis patients were included, with 32 developing myocardial injury and 53 without myocardial injury. There were 40 cases of low expression of CISD2 and 45 cases of high expression of CISD2. At 28 days, 60 cases survived and 25 cases died. The mRNA expression of CISD2 in the SMI group was significantly lower than that in the sepsis non-myocardial injury group (copy/μL: 0.41±0.09 vs. 0.92±0.13, P < 0.05). CISD2 was significantly correlated with myocardial injury in patients with sepsis (r = 0.729, P < 0.05). The proportion of LVEF < 0.50 (67.50% vs. 11.11%), sequential organ failure score (SOFA: 15.63±2.15 vs. 11.12±1.52), and acute physiology and chronic health evaluation II (APACHEII: 29.49±3.51 vs. 22.41±2.61) in t
目的:通过临床研究和细胞实验,探讨CDGSH铁硫结构域2 (CISD2)在败血症相关性心肌损伤(SMI)患者中的作用及其对28天预后和心肌损害的预测价值。方法:回顾性研究。选取2023年1月至2024年1月在齐齐哈尔医科大学第三附属医院重症监护内科确诊为脓毒症的成年患者。收集患者入院后24 h的临床资料、实验室指标、外周血单个核细胞(PBMC)中CISD2 mRNA表达水平及28 d预后。根据左心室射血分数(LVEF) < 0.50或LVEF较基线下降≥10%,将患者分为SMI组和脓毒症非心肌损伤组。比较两组大鼠CISD2 mRNA表达水平,分析CISD2与心肌损伤的相关性。根据CISD2 mRNA表达水平将患者分为低表达组(CISD2 mRNA < 0.5 copy/μL)和高表达组(CISD2 mRNA≥0.5 copy/μL), 28 d时根据预后分为生存组和死亡组。分析两组患者的临床特点。采用多因素Logistic回归分析脓毒症患者28天死亡率的独立预测因素。采用受试者特征曲线(receiver operator characteristic curve, ROC曲线)评价CISD2对脓毒症患者心肌损害及28天预后的预测价值。此外,还利用人AC16心肌细胞进行了体外实验。将细胞分为对照组、脂多糖(LPS)组、过表达CISD2质粒的LPS+转染组(LPS+p-CISD2组)和阴性质粒转染组(LPS+p-NC组)。采用实时定量聚合酶链反应(RT-qPCR)检测细胞中CISD2 mRNA的表达,采用Western blotting检测细胞中CISD2蛋白的表达,采用细胞计数试剂盒-8 (CCK-8)检测细胞活力。结果:共纳入85例败血症患者,32例发生心肌损伤,53例未发生心肌损伤。CISD2低表达40例,高表达45例。28天,存活60例,死亡25例。SMI组CISD2 mRNA表达量显著低于脓毒症非心肌损伤组(拷贝/μL: 0.41±0.09∶0.92±0.13,P < 0.05)。CISD2与脓毒症患者心肌损伤有显著相关性(r = 0.729, P < 0.05)。CISD2低表达组LVEF < 0.50的比例(67.50% vs. 11.11%)、顺序器官衰竭评分(SOFA: 15.63±2.15 vs. 11.12±1.52)、急性生理和慢性健康评估II (APACHEII: 29.49±3.51 vs. 22.41±2.61)均显著高于CISD2高表达组(P均< 0.05),其他指标差异无统计学意义。Kaplan-Meier生存曲线显示,CISD2低表达组脓毒症患者的28天生存时间明显短于CISD2高表达组(Log-rank检验:χ 2 = 5.601, P < 0.05)。生存组中CISD2低表达比例和LVEF < 0.50比例均高于死亡组(80.00%比33.33%,64.00%比26.67%,P均< 0.05),其他指标差异无统计学意义。多因素Logistic回归分析显示,CIDS2和LVEF是脓毒症患者28天死亡率的独立预测因素[CIDS2:优势比(OR) = 3.400, 95%可信区间(95% ci)为1.026 ~ 11.264,P = 0.045;LVEF: OR = 2.905, 95%CI为1.029 ~ 8.199,P = 0.044]。ROC曲线分析显示,当CISD2低水平表达时,脓毒症患者28天内死亡和心肌损伤的风险较高。CISD2预测脓毒症患者28天死亡率的敏感性为80.00%,特异性为66.67%,曲线下面积(AUC)为0.733 (95%CI为0.626 ~ 0.823)。CISD2预测脓毒症患者心肌损伤的敏感性为83.87%,特异性为74.07%,AUC为0.790 (95%CI为0.688-0.871)。此外,与对照组相比,LPS组CISD2 mRNA和蛋白表达量以及细胞活性均显著降低。转染p-CISD2后,心肌细胞中CISD2 mRNA和蛋白的表达及细胞活性均显著升高。结论:CISD2在脓毒症相关心肌损伤中具有保护作用,对28天预后及心肌损伤有较好的预测价值。
{"title":"[The role of CISD2 in sepsis-associated myocardial injury and its predictive value for 28-day prognosis].","authors":"Bingchang Hei, Xiaobing Li, Xianguo Meng, Zhanjiang Guan, Shi Liu","doi":"10.3760/cma.j.cn121430-20250305-00216","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250305-00216","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To explore the role of CDGSH iron-sulfur domain 2 (CISD2) in patients with sepsis-related myocardial injury (SMI) and its predictive value for 28-day prognosis and myocardial damage through clinical studies and cell experiments.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective study was conducted. Adult patients diagnosed with sepsis admitted to the critical care medicine of Third Affiliated Hospital of Qiqihar Medical University from January 2023 to January 2024 were enrolled. The clinical data, laboratory indicators, expression level of CISD2 mRNA in peripheral blood mononuclear cells (PBMC) 24 hours after admission, and 28 days prognosis were collected. Patients were divided into SMI group [left ventricular ejection fraction (LVEF) &lt; 0.50 or LVEF decreased by ≥ 10% from baseline] and sepsis non-myocardial injury group based on LVEF. The expression levels of CISD2 mRNA were compared between the two groups, and the correlation between CISD2 and myocardial injury was analyzed. Patients were divided into the low-expression group (CISD2 mRNA &lt; 0.5 copy/μL) and the high-expression group (CISD2 mRNA ≥ 0.5 copy/μL) based on the expression of CISD2 mRNA, and into the survival group and the death group based on the prognosis at 28 days. The clinical characteristics were analyzed between the groups. Multivariate Logistic regression was used to analyze the independent predictors of 28-day mortality in patients with sepsis. The predictive value of CISD2 for myocardial damage and 28-day prognosis in patients with sepsis were evaluated by using the receiver operator characteristic curve (ROC curve). In addition, in vitro experiments using human AC16 cardiomyocytes was conducted. The cells were divided into control group, lipopolysaccharide (LPS) group, the LPS+transfection group with overexpression of CISD2 plasmid (LPS+p-CISD2 group), and the LPS + transfection group with negative control plasmid (LPS+p-NC group). The mRNA expression of CISD2 in cells were detected by real-time quantitative polymerase chain reaction (RT-qPCR), the protein expression of CISD2 in cells were detected by Western blotting, and the cell viability was determined by cell counting kit-8 (CCK-8).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 85 sepsis patients were included, with 32 developing myocardial injury and 53 without myocardial injury. There were 40 cases of low expression of CISD2 and 45 cases of high expression of CISD2. At 28 days, 60 cases survived and 25 cases died. The mRNA expression of CISD2 in the SMI group was significantly lower than that in the sepsis non-myocardial injury group (copy/μL: 0.41±0.09 vs. 0.92±0.13, P &lt; 0.05). CISD2 was significantly correlated with myocardial injury in patients with sepsis (r = 0.729, P &lt; 0.05). The proportion of LVEF &lt; 0.50 (67.50% vs. 11.11%), sequential organ failure score (SOFA: 15.63±2.15 vs. 11.12±1.52), and acute physiology and chronic health evaluation II (APACHEII: 29.49±3.51 vs. 22.41±2.61) in t","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 8","pages":"721-727"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Feasibility and prognostic value of estimated plasma volume status in assessing volume status during early fluid resuscitation in patients with sepsis]. [估计血浆容量状态在脓毒症患者早期液体复苏中评估容量状态的可行性及预后价值]。
Q3 Medicine Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn121430-20240729-00641
Xiaodong Liu, Fei Wang, Wangbin Xu, Man Yang, Xiao Yang, Dongmei Dai, Leyun Xiao-Li, Xinghui Guan, Xiaoyang Su, Yuemeng Cui, Lei Cai
<p><strong>Objective: </strong>To investigate the feasibility and prognostic implications of assessing volume status during early fluid resuscitation in septic patients based on estimated plasma volume status (ePVS).</p><p><strong>Methods: </strong>A prospective study was conducted. Patients with sepsis admitted to intensive care unit (ICU) of the First Affiliated Hospital of Kunming Medical University from March to December in 2023 were enrolled. The general information and laboratory indicators at ICU admission were recorded, and ePVS, sequential organ failure assessment (SOFA) score, acute physiology and chronic health status evaluation II (APACHE II) score were calculated. The vital signs, arterial blood gas analysis and volume status related indicators before liquid resuscitation (T0h) and 3 hours (T3h) and 6 hours (T6h) of fluid resuscitation were recorded. The diameter and variability of the inferior vena cava (IVC) were measured by ultrasound, and ePVS, percentage change value of estimated plasma volume status (ΔePVS%), difference in central venous-to-arterial partial pressure of carbon dioxide (Pcv-aCO<sub>2</sub>), and lactate clearance rate (LCR) were calculated. Patients were divided into sepsis group and septic shock group based on the diagnosis at ICU admission, and septic patients were subdivided into survival group and death group based on their 28-day survival status. The differences in clinical data between the groups were compared. The correlation between ePVS or ΔePVS% and volume status related indicators during early liquid resuscitation was analyzed by Spearman rank sum correlation test. The predictive value of each variable for 28-day survival in patients with sepsis was analyzed by receiver operator characteristic curve (ROC curve), and 28-day death risk factors were analyzed by Logistic regression method.</p><p><strong>Results: </strong>Fifty-four septic patients were enrolled in the final analysis, including 17 with sepsis and 37 with septic shock; 34 survived at 28 days and 20 died, with a 28-day survival rate of 63.0%. Compared with the sepsis group, the septic shock group had a lower venous ePVS at ICU admission [dL/g: 4.96 (3.67, 7.15) vs. 7.55 (4.36, 10.07), P < 0.05]. Compared with the death group, the survival group had higher T6h arterial and venous ΔePVS%, and albumin [Alb; T6h arterial ΔePVS% (%): 11.57% (-1.82%, 31.35%) vs. 0.48% (-5.67%, 6.02%), T6h venous ΔePVS%: 9.62% (3.59%, 25.75%) vs. 1.52% (-9.65%, 7.72%), Alb (g/L): 27.57±4.15 vs. 23.77±6.97, all P < 0.05], lower SOFA score, APACHE II score, AST, T0h Lac, and T3h and T6h norepinephrine dosage [SOFA score: 9.00 (8.00, 10.00) vs. 11.50 (9.25, 14.50), APACHE II score: 18.00 (14.75, 21.25) vs. 25.50 (21.00, 30.00), AST (U/L): 34.09 (23.20, 56.64) vs. 79.24 (25.34, 196.59), T0h Lac (mmol/L): 1.75 (1.40, 2.93) vs. 3.25 (2.33, 5.30), norepinephrine dosage (mg): 0.98 (< 0.01, 3.10) vs. 4.60 (1.05, 8.55) at T3h, 1.82 (0.38, 5.30) vs. 8.20 (2.80, 17.73) at T6h,
目的:探讨基于血浆容量状态(ePVS)评估脓毒症患者早期液体复苏时容量状态的可行性及其预后意义。方法:采用前瞻性研究。研究对象为2023年3月至12月昆明医科大学第一附属医院重症监护室(ICU)收治的脓毒症患者。记录患者入院时的一般信息及实验室指标,计算ePVS、顺序器官衰竭评分(SOFA)、急性生理和慢性健康状态评估ⅱ(APACHE II)评分。记录液体复苏前(T0h)和液体复苏后3小时(T3h)、6小时(T6h)的生命体征、动脉血气分析及容积状态相关指标。超声测量下腔静脉(IVC)直径和变异性,计算ePVS、估计血浆容量状态百分比变化值(ΔePVS%)、中心静脉-动脉二氧化碳分压差(Pcv-aCO2)和乳酸清除率(LCR)。脓毒症患者根据入院时的诊断分为脓毒症组和脓毒症休克组,脓毒症患者根据28天生存情况分为生存组和死亡组。比较两组临床资料的差异。采用Spearman秩和相关检验分析早期液体复苏时ePVS或ΔePVS%与容积状态相关指标的相关性。采用受试者操作者特征曲线(receiver operator characteristic curve, ROC)分析各变量对脓毒症患者28天生存的预测价值,采用Logistic回归方法分析28天死亡危险因素。结果:最终纳入54例脓毒症患者,其中脓毒症17例,脓毒症休克37例;28 d存活34只,死亡20只,28 d生存率为63.0%。与脓毒症组相比,脓毒症休克组入院时静脉ePVS较低[dL/g: 4.96(3.67, 7.15)比7.55 (4.36,10.07),P < 0.05]。与死亡组比较,生存组T6h动脉和静脉ΔePVS%,白蛋白[Alb;T6h动脉ΔePVS% (%): 11.57% (-1.82%, 31.35%) vs. 0.48% (-5.67%, 6.02%), T6h静脉ΔePVS%: 9.62% (3.59%, 25.75%) vs. 1.52% (-9.65%, 7.72%), Alb (g/L): 27.57±4.15 vs. 23.77±6.97,均P < 0.05),较低的SOFA评分,APACHE II评分,AST, T0h Lac, T3h和T6h去甲肾上腺素用量[SOFA评分:9.00 (8.00,10.00)vs. 11.50 (9.25, 14.50), APACHE II评分:18.00 (14.75,21.25)vs. 25.50 (21.00, 30.00), AST (U/L): 34.09 (23.20, 56.64) vs. 79.24 (25.34, 196.59), T0h Lac (mmol/L):1.75(1.40, 2.93)比3.25 (2.33,5.30),T3h去甲肾上腺素剂量(mg): 0.98(< 0.01, 3.10)比4.60 (1.05,8.55),T6h 1.82(0.38, 5.30)比8.20 (2.80,17.73),P均< 0.05]。而两组在复苏前后各时间点的其他基本数据和ePVS均无显著差异。相关分析显示,脓毒症患者T6h静脉ePVS与T6h IVC变异性显著正相关(r = 0.360, P < 0.05), T0h动脉ePVS与T3h、T6h进液量显著负相关(r1 = -0.367, r2 = -0.280,均P < 0.05), ICU入院静脉ePVS与ICU入院NT-proBNP显著正相关(r = 0.409, P < 0.05)。T6h静脉ΔePVS%与T3h进液量、T6h LCR呈显著正相关(r1 = 0.286, r2 = 0.286, P < 0.05),与T6h尿量、T6h Pcv-aCO2变化值呈显著负相关(ΔPcv-aCO2; r1 = -0.321, r2 = -0.371, P < 0.05)。ROC曲线分析显示,T6h静脉ΔePVS%预测脓毒症患者28天生存的ROC曲线下面积(AUC)为0.726[95%可信区间(95% ci)为0.578 ~ 0.875,P = 0.006],敏感性为82.4%,特异性为60.0%,最佳临界值为3.09%。二元多因素Logistic回归分析显示,T6h静脉ΔePVS%升高是脓毒症患者早期液体复苏28天死亡的保护因素[优势比(OR) = 0.900, 95%CI为0.834-0.972,P = 0.007]。结论:ePVS可能有潜力评估脓毒症患者早期液体复苏时的容量状况。早期液体复苏时ΔePVS%有助于鉴别预后不良的脓毒症患者。
{"title":"[Feasibility and prognostic value of estimated plasma volume status in assessing volume status during early fluid resuscitation in patients with sepsis].","authors":"Xiaodong Liu, Fei Wang, Wangbin Xu, Man Yang, Xiao Yang, Dongmei Dai, Leyun Xiao-Li, Xinghui Guan, Xiaoyang Su, Yuemeng Cui, Lei Cai","doi":"10.3760/cma.j.cn121430-20240729-00641","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240729-00641","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the feasibility and prognostic implications of assessing volume status during early fluid resuscitation in septic patients based on estimated plasma volume status (ePVS).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A prospective study was conducted. Patients with sepsis admitted to intensive care unit (ICU) of the First Affiliated Hospital of Kunming Medical University from March to December in 2023 were enrolled. The general information and laboratory indicators at ICU admission were recorded, and ePVS, sequential organ failure assessment (SOFA) score, acute physiology and chronic health status evaluation II (APACHE II) score were calculated. The vital signs, arterial blood gas analysis and volume status related indicators before liquid resuscitation (T0h) and 3 hours (T3h) and 6 hours (T6h) of fluid resuscitation were recorded. The diameter and variability of the inferior vena cava (IVC) were measured by ultrasound, and ePVS, percentage change value of estimated plasma volume status (ΔePVS%), difference in central venous-to-arterial partial pressure of carbon dioxide (Pcv-aCO&lt;sub&gt;2&lt;/sub&gt;), and lactate clearance rate (LCR) were calculated. Patients were divided into sepsis group and septic shock group based on the diagnosis at ICU admission, and septic patients were subdivided into survival group and death group based on their 28-day survival status. The differences in clinical data between the groups were compared. The correlation between ePVS or ΔePVS% and volume status related indicators during early liquid resuscitation was analyzed by Spearman rank sum correlation test. The predictive value of each variable for 28-day survival in patients with sepsis was analyzed by receiver operator characteristic curve (ROC curve), and 28-day death risk factors were analyzed by Logistic regression method.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Fifty-four septic patients were enrolled in the final analysis, including 17 with sepsis and 37 with septic shock; 34 survived at 28 days and 20 died, with a 28-day survival rate of 63.0%. Compared with the sepsis group, the septic shock group had a lower venous ePVS at ICU admission [dL/g: 4.96 (3.67, 7.15) vs. 7.55 (4.36, 10.07), P &lt; 0.05]. Compared with the death group, the survival group had higher T6h arterial and venous ΔePVS%, and albumin [Alb; T6h arterial ΔePVS% (%): 11.57% (-1.82%, 31.35%) vs. 0.48% (-5.67%, 6.02%), T6h venous ΔePVS%: 9.62% (3.59%, 25.75%) vs. 1.52% (-9.65%, 7.72%), Alb (g/L): 27.57±4.15 vs. 23.77±6.97, all P &lt; 0.05], lower SOFA score, APACHE II score, AST, T0h Lac, and T3h and T6h norepinephrine dosage [SOFA score: 9.00 (8.00, 10.00) vs. 11.50 (9.25, 14.50), APACHE II score: 18.00 (14.75, 21.25) vs. 25.50 (21.00, 30.00), AST (U/L): 34.09 (23.20, 56.64) vs. 79.24 (25.34, 196.59), T0h Lac (mmol/L): 1.75 (1.40, 2.93) vs. 3.25 (2.33, 5.30), norepinephrine dosage (mg): 0.98 (&lt; 0.01, 3.10) vs. 4.60 (1.05, 8.55) at T3h, 1.82 (0.38, 5.30) vs. 8.20 (2.80, 17.73) at T6h, ","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 7","pages":"620-627"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Exploring critical thinking in the management of diagnosis and treatment of fulminant pregnancy-associated atypical haemolytic uraemic syndrome]. [探讨暴发型妊娠相关非典型溶血性尿毒症综合征诊治管理中的批判性思维]。
Q3 Medicine Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn121430-20250417-00375
Fei Gao, Lunsheng Jiang, Shan Ma, Yuantuan Yao, Wanping Ao, Bao Fu
<p><p>Critical care emphasizes critical thinking, focuses on the triggers that lead to disease progression, and attaches great importance to early diagnosis of diseases and assessment of the compensatory capacity of vital organs. Pregnancy-associated atypical hemolytic uremic syndrome (P-aHUS) is relatively rare in the intensive care unit (ICU). Most cases occur within 10 weeks after delivery. Severe cases can be life-threatening. It characterized by microangiopathic hemolytic anemia, decreased platelet count (PLT), and acute kidney injury (AKI). Early clinical diagnosis is difficult due to its similarity to various disease manifestations. On January 28, 2024, a 26-year-old pregnant woman at 26<sup>+3</sup> weeks gestation was transferred to the ICU 19 hours post-vaginal delivery due to abdominal pain, reduced urine output, decreased PLT, elevated D-dimer, tachycardia, increased respiratory rate and declined oxygenation. On the day of ICU admission, the critical care physician identified the causes that triggered the acute respiratory and circulatory events based on the "holistic and local" critical care thinking. The condition was stabilized rapidly by improving the capacity overload. In terms of etiological diagnosis, under the guidance of the "point and face" critical care thinking, starting from abnormality indicators including a decrease in hemoglobin (Hb) and PLT and elevated D-dimer and fibrin degradation product (FDP) without other abnormal coagulation indicators, the critical care physician ultimately determined the diagnosis direction of thrombotic microangiopathy (TMA) by delving deeply into the essence of the disease and formulating a laboratory examination plan in a reasonable and orderly manner. In terms of in-depth diagnosis, combining the disease development process, family history, and past history, applying the two-way falsification thinking of "forward and reverse" as well as "questioning and hypothesis", the diagnosis possibilities of preeclampsia, HELLP syndrome [including hemolysis (H), elevated liver function (EL) and low platelet count (LP)], thrombotic thrombocytopenic purpura (TTP), typical hemolytic uremic syndrome (HUS), and autoimmune inflammatory diseases inducing the condition was ruled out. The diagnosis of complement activation-induced P-aHUS was finally established for the patient, according to the positive result of the complement factor H (CFH). Active decision was made in the initial treatment. The plasma exchange was initiated early. "Small goals" were formulated in stages. The "small endpoints" were dynamically controlled in a goal-oriented manner to achieve continuous realization of the overall treatment effect through phased "small goals". On the 5th day of ICU treatment, the trend of microthrombosis in the patient was controlled, organ function damage was improved, and the patient was transferred out of the ICU. It is possible to reach a favorable clinical outcome for critically ill patients by applying a
重症监护强调批判性思维,关注导致疾病进展的触发因素,重视疾病的早期诊断和重要器官代偿能力的评估。妊娠相关非典型溶血性尿毒症综合征(P-aHUS)在重症监护病房(ICU)相对罕见。大多数病例发生在分娩后10周内。严重的病例可能危及生命。其特点是微血管性溶血性贫血,血小板计数(PLT)下降,急性肾损伤(AKI)。该病与多种疾病表现相似,临床早期诊断困难。2024年1月28日,一位26岁孕26+3周的孕妇,因腹痛、尿量减少、PLT降低、d -二聚体升高、心动过速、呼吸频率增加、氧合下降,于阴道分娩后19小时转至ICU。入住ICU当天,重症监护医师基于“整体与局部”的重症监护思维,识别引发急性呼吸循环事件的原因。通过改进容量过载,使该状况迅速稳定下来。病因诊断方面,在“点与面”重症监护思维指导下,从血红蛋白(Hb)、PLT下降、d -二聚体、纤维蛋白降解产物(FDP)升高等异常指标入手,无其他凝血指标异常;重症医师通过深入探究疾病本质,合理有序地制定实验室检查计划,最终确定血栓性微血管病(TMA)的诊断方向。在深入诊断方面,结合疾病发展过程、家族史、既往史,运用“正反”、“质疑与假设”的双向证伪思维,对先兆子痫、HELLP综合征(包括溶血(H)、肝功能升高(EL)、血小板计数低(LP))、血栓性血小板减少性紫癜(TTP)、典型溶血性尿毒症综合征(HUS)、自身免疫性炎症导致的病症也被排除了。根据补体因子H (CFH)阳性结果,最终确定患者补体活化诱导P-aHUS的诊断。在最初的治疗中就做出了积极的决定。血浆置换很早就开始了。“小目标”是分阶段制定的。以目标为导向,对“小终点”进行动态控制,通过阶段性“小目标”实现整体治疗效果的持续实现。在ICU治疗第5天,患者微血栓形成趋势得到控制,器官功能损害得到改善,患者转出ICU。运用危重监护思维,快速整合诊断与治疗策略,准确识别导致疾病进展的诱因和原因,运用危重监护医学技术进行早期有效的干预,才有可能为危重患者取得良好的临床结果。
{"title":"[Exploring critical thinking in the management of diagnosis and treatment of fulminant pregnancy-associated atypical haemolytic uraemic syndrome].","authors":"Fei Gao, Lunsheng Jiang, Shan Ma, Yuantuan Yao, Wanping Ao, Bao Fu","doi":"10.3760/cma.j.cn121430-20250417-00375","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250417-00375","url":null,"abstract":"&lt;p&gt;&lt;p&gt;Critical care emphasizes critical thinking, focuses on the triggers that lead to disease progression, and attaches great importance to early diagnosis of diseases and assessment of the compensatory capacity of vital organs. Pregnancy-associated atypical hemolytic uremic syndrome (P-aHUS) is relatively rare in the intensive care unit (ICU). Most cases occur within 10 weeks after delivery. Severe cases can be life-threatening. It characterized by microangiopathic hemolytic anemia, decreased platelet count (PLT), and acute kidney injury (AKI). Early clinical diagnosis is difficult due to its similarity to various disease manifestations. On January 28, 2024, a 26-year-old pregnant woman at 26&lt;sup&gt;+3&lt;/sup&gt; weeks gestation was transferred to the ICU 19 hours post-vaginal delivery due to abdominal pain, reduced urine output, decreased PLT, elevated D-dimer, tachycardia, increased respiratory rate and declined oxygenation. On the day of ICU admission, the critical care physician identified the causes that triggered the acute respiratory and circulatory events based on the \"holistic and local\" critical care thinking. The condition was stabilized rapidly by improving the capacity overload. In terms of etiological diagnosis, under the guidance of the \"point and face\" critical care thinking, starting from abnormality indicators including a decrease in hemoglobin (Hb) and PLT and elevated D-dimer and fibrin degradation product (FDP) without other abnormal coagulation indicators, the critical care physician ultimately determined the diagnosis direction of thrombotic microangiopathy (TMA) by delving deeply into the essence of the disease and formulating a laboratory examination plan in a reasonable and orderly manner. In terms of in-depth diagnosis, combining the disease development process, family history, and past history, applying the two-way falsification thinking of \"forward and reverse\" as well as \"questioning and hypothesis\", the diagnosis possibilities of preeclampsia, HELLP syndrome [including hemolysis (H), elevated liver function (EL) and low platelet count (LP)], thrombotic thrombocytopenic purpura (TTP), typical hemolytic uremic syndrome (HUS), and autoimmune inflammatory diseases inducing the condition was ruled out. The diagnosis of complement activation-induced P-aHUS was finally established for the patient, according to the positive result of the complement factor H (CFH). Active decision was made in the initial treatment. The plasma exchange was initiated early. \"Small goals\" were formulated in stages. The \"small endpoints\" were dynamically controlled in a goal-oriented manner to achieve continuous realization of the overall treatment effect through phased \"small goals\". On the 5th day of ICU treatment, the trend of microthrombosis in the patient was controlled, organ function damage was improved, and the patient was transferred out of the ICU. It is possible to reach a favorable clinical outcome for critically ill patients by applying a","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 7","pages":"680-683"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Protective mechanism of modulating cyclic guanosine monophosphate-adenosine monophosphate synthase/stimulator of interferon gene pathway in oleic acid-induced acute lung injury in mice]. [调节环鸟苷单磷酸-腺苷单磷酸合成酶/干扰素基因通路刺激因子对油酸致小鼠急性肺损伤的保护机制]。
Q3 Medicine Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn121430-20250104-00012
Liangyu Mi, Wenyan Ding, Yingying Yang, Qianlin Wang, Xiangyu Chen, Ziqi Tan, Xiaoyu Zhang, Min Zheng, Longxiang Su, Yun Long
<p><strong>Objective: </strong>To investigate the role and mechanism of the cyclic guanosine monophosphate-adenosine monophosphate synthase/stimulator of interferon gene (cGAS/STING) pathway in oleic acid-induced acute lung injury (ALI) in mice.</p><p><strong>Methods: </strong>Male wild-type C57BL/6J mice were randomly divided into five groups (each n = 10): normal control group, ALI model group, and 5, 50, 500 μg/kg inhibitor pretreatment groups. The ALI model was established by tail vein injection of oleic acid (7 mL/kg), while the normal control group received no intervention. The inhibitor pretreatment groups were intraperitoneally injected with the corresponding doses of cGAS inhibitor RU.521 respectively 1 hour before modeling. At 24 hours post-modeling, blood was collected, and mice were sacrificed. Lung tissue pathological changes were observed under light microscopy after hematoxylin-eosin (HE) staining, and pathological scores were assessed. Western blotting was used to detect the protein expressions of cGAS, STING, phosphorylated TANK-binding kinase 1 (p-TBK1), phosphorylated interferon regulatory factor 3 (p-IRF3), and phosphorylated nuclear factor-κB p65 (p-NF-κB p65) in lung tissue. Immunohistochemistry was performed to observe STING and p-NF-κB positive expressions in lung tissue. Serum interferon-β (IFN-β) levels were measured by enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong>Compared with the normal control group, the ALI model group exhibited significant focal alveolar thickening, intra-alveolar hemorrhage, pulmonary capillary congestion, and neutrophil infiltration in the pulmonary interstitium and alveoli, along with markedly increased pathological scores (10.33±0.58 vs. 1.33±0.58, P < 0.05). Protein expressions of cGAS, STING, p-TBK1, p-IRF3, and p-NF-κB p65 in lung tissue significantly increased [cGAS protein (cGAS/β-actin): 1.24±0.02 vs. 0.56±0.02, STING protein (STING/β-actin): 1.27±0.01 vs. 0.55±0.01, p-TBK1 protin (p-TBK1/β-actin): 1.34±0.03 vs. 0.22±0.01, p-IRF3 protein (p-IRF3/β-actin): 1.23±0.02 vs. 0.36±0.01, p-NF-κB p65 protein (p-NF-κB p65/β-actin): 1.30±0.02 vs. 0.53±0.02, all P < 0.05], positive expressions of STING and p-NF-κB in lung tissue were significantly elevated [STING (A value): 0.51±0.03 vs. 0.30±0.07, p-NF-κB (A value): 0.57±0.05 vs. 0.31±0.03, both P < 0.05], and serum IFN-β levels were also significantly higher (ng/L: 256.02±3.84 vs. 64.15±1.17, P < 0.05). The cGAS inhibitor pretreatment groups showed restored alveolar structural integrity, reduced inflammatory cell infiltration, and decreased hemorrhage area, along with dose-dependent lower pathological scores as well as the protein expressions of cGAS, STING, p-TBK1, p-IRF3 and p-NF-κB p65 in lung tissue, with significant differences between the 500 μg/kg inhibitor group and ALI model group [pathological score: 2.67±0.58 vs. 10.33±0.58, cGAS protein (cGAS/β-actin): 0.56±0.03 vs. 1.24±0.02, STING protein (STING/β-actin):
目的:探讨环鸟苷单磷酸-腺苷单磷酸合成酶/干扰素基因刺激因子(cGAS/STING)通路在油酸致小鼠急性肺损伤(ALI)中的作用及机制。方法:将雄性野生型C57BL/6J小鼠随机分为正常对照组、ALI模型组和5、50、500 μg/kg抑制剂预处理组,每组10只。通过尾静脉注射油酸(7 mL/kg)建立ALI模型,正常对照组不进行干预。抑制剂预处理组在造模前1 h分别腹腔注射相应剂量的cGAS抑制剂RU.521。造模后24小时采血,处死小鼠。苏木精-伊红(HE)染色后光镜下观察肺组织病理变化,并进行病理评分。Western blotting检测肺组织中cGAS、STING、磷酸化tank结合激酶1 (p-TBK1)、磷酸化干扰素调节因子3 (p-IRF3)、磷酸化核因子-κB p65 (p-NF-κB p65)蛋白的表达。免疫组化观察肺组织中STING和p-NF-κB的阳性表达。采用酶联免疫吸附试验(ELISA)检测血清干扰素-β (IFN-β)水平。结果:与正常对照组比较,ALI模型组大鼠肺泡局灶性增厚、肺泡内出血、肺毛细血管充血、肺间质及肺泡中性粒细胞浸润明显增多,病理评分明显升高(10.33±0.58∶1.33±0.58,P < 0.05)。肺组织中cGAS、STING、p-TBK1、p-IRF3、p-NF-κB p65蛋白表达显著升高[cGAS蛋白(cGAS/β-actin): 1.24±0.02比0.56±0.02,STING蛋白(STING/β-actin): 1.27±0.01比0.55±0.01,p-TBK1蛋白(p-TBK1/β-actin): 1.34±0.03比0.22±0.01,p-IRF3蛋白(p-IRF3/β-actin): 1.23±0.02比0.36±0.01,p-NF-κB p65蛋白(p-NF-κB p65/β-actin):1.30±0.02比0.53±0.02,P < 0.05],肺组织中STING和P - nf -κB阳性表达显著升高[STING (A值):0.51±0.03比0.30±0.07,P - nf -κB (A值):0.57±0.05比0.31±0.03,P < 0.05],血清中IFN-β水平也显著升高(ng/L: 256.02±3.84比64.15±1.17,P < 0.05)。cGAS抑制剂预处理组肺泡结构完整性恢复,炎症细胞浸润减少,出血面积减小,肺组织cGAS、STING、p-TBK1、p-IRF3、p-NF-κB p65蛋白表达呈剂量依赖性降低,病理评分降低,500 μg/kg抑制剂组与ALI模型组比较差异有统计学意义[cGAS蛋白(cGAS/β-actin)病理评分:2.67±0.58∶10.33±0.58];0.56±0.03比1.24±0.02,STING蛋白(STING/β-actin): 0.67±0.03比1.27±0.01,P - tbk1蛋白(P - tbk1 /β-actin): 0.28±0.01比1.34±0.03,P - irf3蛋白(P - irf3 /β-actin): 0.32±0.01比1.23±0.02,P - nf -κB p65蛋白(P - nf -κB p65/β-actin): 0.63±0.01比1.30±0.02,均P < 0.05]。与ALI模型组比较,500 μg/kg抑制剂组肺组织中STING、P - nf -κB阳性表达明显降低[STING (A值):0.40±0.01 vs. 0.51±0.03,P - nf -κB (A值):0.43±0.02 vs. 0.57±0.05,P < 0.05],血清中IFN-β水平也明显降低(ng/L: 150.03±6.19 vs. 256.02±3.84,P < 0.05)。结论:油酸诱导的ALI中cGAS/STING通路被激活,导致炎症反应加重,肺损伤加重。RU.521可以抑制cGAS,从而下调通路蛋白和细胞因子的表达,对肺组织起到保护作用。
{"title":"[Protective mechanism of modulating cyclic guanosine monophosphate-adenosine monophosphate synthase/stimulator of interferon gene pathway in oleic acid-induced acute lung injury in mice].","authors":"Liangyu Mi, Wenyan Ding, Yingying Yang, Qianlin Wang, Xiangyu Chen, Ziqi Tan, Xiaoyu Zhang, Min Zheng, Longxiang Su, Yun Long","doi":"10.3760/cma.j.cn121430-20250104-00012","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20250104-00012","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the role and mechanism of the cyclic guanosine monophosphate-adenosine monophosphate synthase/stimulator of interferon gene (cGAS/STING) pathway in oleic acid-induced acute lung injury (ALI) in mice.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Male wild-type C57BL/6J mice were randomly divided into five groups (each n = 10): normal control group, ALI model group, and 5, 50, 500 μg/kg inhibitor pretreatment groups. The ALI model was established by tail vein injection of oleic acid (7 mL/kg), while the normal control group received no intervention. The inhibitor pretreatment groups were intraperitoneally injected with the corresponding doses of cGAS inhibitor RU.521 respectively 1 hour before modeling. At 24 hours post-modeling, blood was collected, and mice were sacrificed. Lung tissue pathological changes were observed under light microscopy after hematoxylin-eosin (HE) staining, and pathological scores were assessed. Western blotting was used to detect the protein expressions of cGAS, STING, phosphorylated TANK-binding kinase 1 (p-TBK1), phosphorylated interferon regulatory factor 3 (p-IRF3), and phosphorylated nuclear factor-κB p65 (p-NF-κB p65) in lung tissue. Immunohistochemistry was performed to observe STING and p-NF-κB positive expressions in lung tissue. Serum interferon-β (IFN-β) levels were measured by enzyme-linked immunosorbent assay (ELISA).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Compared with the normal control group, the ALI model group exhibited significant focal alveolar thickening, intra-alveolar hemorrhage, pulmonary capillary congestion, and neutrophil infiltration in the pulmonary interstitium and alveoli, along with markedly increased pathological scores (10.33±0.58 vs. 1.33±0.58, P &lt; 0.05). Protein expressions of cGAS, STING, p-TBK1, p-IRF3, and p-NF-κB p65 in lung tissue significantly increased [cGAS protein (cGAS/β-actin): 1.24±0.02 vs. 0.56±0.02, STING protein (STING/β-actin): 1.27±0.01 vs. 0.55±0.01, p-TBK1 protin (p-TBK1/β-actin): 1.34±0.03 vs. 0.22±0.01, p-IRF3 protein (p-IRF3/β-actin): 1.23±0.02 vs. 0.36±0.01, p-NF-κB p65 protein (p-NF-κB p65/β-actin): 1.30±0.02 vs. 0.53±0.02, all P &lt; 0.05], positive expressions of STING and p-NF-κB in lung tissue were significantly elevated [STING (A value): 0.51±0.03 vs. 0.30±0.07, p-NF-κB (A value): 0.57±0.05 vs. 0.31±0.03, both P &lt; 0.05], and serum IFN-β levels were also significantly higher (ng/L: 256.02±3.84 vs. 64.15±1.17, P &lt; 0.05). The cGAS inhibitor pretreatment groups showed restored alveolar structural integrity, reduced inflammatory cell infiltration, and decreased hemorrhage area, along with dose-dependent lower pathological scores as well as the protein expressions of cGAS, STING, p-TBK1, p-IRF3 and p-NF-κB p65 in lung tissue, with significant differences between the 500 μg/kg inhibitor group and ALI model group [pathological score: 2.67±0.58 vs. 10.33±0.58, cGAS protein (cGAS/β-actin): 0.56±0.03 vs. 1.24±0.02, STING protein (STING/β-actin): ","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 7","pages":"651-656"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Construction and application of critical care system based on regional coordination]. [基于区域协调的重症监护体系建设与应用]。
Q3 Medicine Pub Date : 2025-07-01 DOI: 10.3760/cma.j.cn121430-20240627-00548
Yongguang Yang, Xinliang Liang, Jingge Zhao, Jianpeng Jiao, Erdan Huang, Jing Li, Lei Qi, Lifang Zhang

In the context of continuously deepening medical and health system reforms and comprehensively promoting the "Healthy China" strategy, Henan Provincial People's Hospital has established a regional collaborative and vertically integrated critical care service structure and network. This initiative aims to enhance information empowerment, strengthen regional collaboration, improve the insufficient primary medical services, and ensure timely and effective treatment for critically ill patients. By establishing a comprehensive dispatch service platform for regional collaborative critical care, building a "top-down" remote medical collaboration network, and forming a cross-regional specialty alliance for critical care, the hospital has improved the efficiency of medical services and enhanced regional capabilities for treating critically ill patients. Simultaneously, for critically serious patients and those with complex diseases at primary medical institutions, a one-stop consultation and referral service has been implemented. This service adopts a "three specialists" approach and a multidisciplinary consultation mechanism within the hospital, constructs a multi-dimensional critical care transfer mode integrating air, ground, and the internet, creates a regional collaborative rescue mode, and implements full-cycle treatment for critically serious patients. The comprehensive, flexible, and efficient service pathway for regional collaborative critical care established by this system ensures timely and safe treatment for critically ill patients, promotes the distribution of high-quality medical resources, and effectively addresses issues such as uneven distribution of high-quality medical resources and varying levels of critical care capabilities. It has facilitated the formation of a new tiered diagnosis and treatment order characterized by "first diagnosis at the primary level, two-way referral, separate treatment for acute and chronic diseases, and vertical integration". This approach has enhanced the diagnostic and comprehensive service capabilities of primary medical institutions. Currently, by strengthening information empowerment and sharing, creating a full-process critical care diagnosis and treatment model, providing medical assistance and cultivating primary-level critical care talent, and promoting appropriate technologies, the hospital has gradually overcome challenges such as barriers to information exchange and sharing between hospitals, overloaded critical care teams, high pressure on patient reception and transfer, and limited critical care capabilities at primary medical institutions. This article summarizes the construction and practical application of this regionally coordinated critical care system, aiming to provide a reference for the management of critical care treatment.

在医药卫生体制改革不断深化、“健康中国”战略全面推进的背景下,河南省人民医院建立了区域协同、垂直一体化的重症监护服务架构和网络。这一举措旨在增强信息权能,加强区域协作,改善初级医疗服务不足的状况,并确保及时有效地治疗危重病人。通过建立区域协同重症监护综合调度服务平台,构建“自上而下”的远程医疗协作网络,形成跨区域的重症监护专科联盟,提高了医疗服务效率,增强了区域救治危重患者的能力。同时,对在基层医疗机构就诊的危重患者和疑难杂症患者,实行一站式会诊转诊服务。该服务采用“三专家”模式和院内多学科会诊机制,构建空中、地面、互联网一体化的多维度重症监护转运模式,开创区域协同救治模式,对危重患者实行全周期救治。该系统建立了全面、灵活、高效的区域协同重症监护服务路径,保证了重症患者得到及时、安全的救治,促进了优质医疗资源的配置,有效解决了优质医疗资源分布不均、重症监护能力参差不齐等问题。促进形成了“初级初诊、双向转诊、急慢性分开治疗、纵向一体化”的分级诊疗新秩序。提高了基层医疗机构的诊断能力和综合服务能力。目前,该院通过加强信息赋能与共享、打造重症全流程诊疗模式、提供医疗救助与培养基层重症人才、推广相应技术,逐步克服了医院间信息交流与共享障碍、重症监护团队超载、患者接收和转院压力大、初级医疗机构的重症监护能力有限。本文对该区域协同重症监护系统的构建及实际应用进行了总结,旨在为重症监护救治管理提供参考。
{"title":"[Construction and application of critical care system based on regional coordination].","authors":"Yongguang Yang, Xinliang Liang, Jingge Zhao, Jianpeng Jiao, Erdan Huang, Jing Li, Lei Qi, Lifang Zhang","doi":"10.3760/cma.j.cn121430-20240627-00548","DOIUrl":"https://doi.org/10.3760/cma.j.cn121430-20240627-00548","url":null,"abstract":"<p><p>In the context of continuously deepening medical and health system reforms and comprehensively promoting the \"Healthy China\" strategy, Henan Provincial People's Hospital has established a regional collaborative and vertically integrated critical care service structure and network. This initiative aims to enhance information empowerment, strengthen regional collaboration, improve the insufficient primary medical services, and ensure timely and effective treatment for critically ill patients. By establishing a comprehensive dispatch service platform for regional collaborative critical care, building a \"top-down\" remote medical collaboration network, and forming a cross-regional specialty alliance for critical care, the hospital has improved the efficiency of medical services and enhanced regional capabilities for treating critically ill patients. Simultaneously, for critically serious patients and those with complex diseases at primary medical institutions, a one-stop consultation and referral service has been implemented. This service adopts a \"three specialists\" approach and a multidisciplinary consultation mechanism within the hospital, constructs a multi-dimensional critical care transfer mode integrating air, ground, and the internet, creates a regional collaborative rescue mode, and implements full-cycle treatment for critically serious patients. The comprehensive, flexible, and efficient service pathway for regional collaborative critical care established by this system ensures timely and safe treatment for critically ill patients, promotes the distribution of high-quality medical resources, and effectively addresses issues such as uneven distribution of high-quality medical resources and varying levels of critical care capabilities. It has facilitated the formation of a new tiered diagnosis and treatment order characterized by \"first diagnosis at the primary level, two-way referral, separate treatment for acute and chronic diseases, and vertical integration\". This approach has enhanced the diagnostic and comprehensive service capabilities of primary medical institutions. Currently, by strengthening information empowerment and sharing, creating a full-process critical care diagnosis and treatment model, providing medical assistance and cultivating primary-level critical care talent, and promoting appropriate technologies, the hospital has gradually overcome challenges such as barriers to information exchange and sharing between hospitals, overloaded critical care teams, high pressure on patient reception and transfer, and limited critical care capabilities at primary medical institutions. This article summarizes the construction and practical application of this regionally coordinated critical care system, aiming to provide a reference for the management of critical care treatment.</p>","PeriodicalId":24079,"journal":{"name":"Zhonghua wei zhong bing ji jiu yi xue","volume":"37 7","pages":"671-675"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zhonghua wei zhong bing ji jiu yi xue
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1